61 results
Page 3 of 4
8-K
EX-1.1
6n71kb
17 Dec 20
Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program
7:05am
DEFA14A
wdcjswe
28 May 20
Additional proxy soliciting materials
4:00pm
8-K
EX-1.1
hjb80atl
22 May 20
Entry into a Material Definitive Agreement
4:14pm
DEFA14A
agjl1glotn43ebkc
22 Apr 20
Additional proxy soliciting materials
6:08am
8-K
EX-10.1
lyjq7e4hdzakdtfifpx
25 Nov 19
Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
8:07am
S-3
EX-1.2
87ihxzq03w h4ye
1 May 19
Shelf registration
8:02am
S-3
EX-4.3
k4sff5j9v5pot esz
1 May 19
Shelf registration
8:02am
S-3
EX-4.2
1ls6jp dykyk8yh43u
1 May 19
Shelf registration
8:02am
DEFA14A
17ln6t2t1w z1
19 Apr 19
Additional proxy soliciting materials
6:07am
DEF 14A
jxgapi
19 Apr 19
Definitive proxy
6:04am
10-K
1k6h 929pzv5bkh3f
7 Mar 19
Annual report
4:13pm
10-Q
3fzhjc7ibu1h
29 May 18
Quarterly report
5:11pm
8-K
EX-10.1
8yn41s3bd7oz o9pq
24 May 18
Entry into a Material Definitive Agreement
4:27pm